ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses

Wang, Yingdan; Liu, Meiqin; Shen, Yaping; Ma, Yunping; Li, Xiang; Zhang, Yuanyuan; Liu, Mei; Yang, Xing-Lou; Chen, Jun; Yan, Renhong; Luan, Die; Wang, Yanqun; Chen, Ying; Wang, Qimin; Lin, Haofeng; Li, Yaning; Wu, Kaiyue; Zhu, Tongyu; Zhao, Jincun; Lu, Hongzhou; Wen, Yumei; Jiang, Shibo; Wu, Fan; Zhou, Qiang; Shi, Zheng-Li; Huang, Jinghe复旦大学; 广州医学院; 清华大学; 上海交通大学; 中国医学科学院; 中国科学院研究生院; 中国科学院; 1
Cell Discovery2022-4-21DOI: 10.1038/s41421-022-00401-6
18被引8阅读
引用收藏
分享

摘要

The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern, including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529) has aroused concerns over their increased infectivity and transmissibility, as well as decreased sensitivity to SARS-CoV-2-neutralizing antibodies (NAbs) and the current coronavirus disease 2019 (COVID-19) vaccines. Such exigencies call for the development of pan-sarbecovirus vaccines or inhibitors to combat the circulating SARS-CoV-2 NAb-escape variants and other sarbecoviruses. In this study, we isolated a broadly NAb against sarbecoviruses named GW01 from a donor who recovered from COVID-19. Cryo-EM structure and competition assay revealed that GW01 targets a highly conserved epitope in a wide spectrum of different sarbecoviruses. However, we found that GW01, the well-known sarbecovirus NAb S309, and the potent SARS-CoV-2 NAbs CC12.1 and REGN10989 only neutralize about 90% of the 56 tested currently circulating variants of SARS-CoV-2 including Omicron. Therefore, to improve efficacy, we engineered an IgG-like bispecific antibody GW01-REGN10989 (G9) consisting of single-chain antibody fragments (scFv) of GW01 and REGN10989. We found that G9 could neutralize 100% of NAb-escape mutants (23 out of 23), including Omicron variant, with a geometric mean (GM) 50% inhibitory concentration of 8.8 ng/mL. G9 showed prophylactic and therapeutic effects against SARS-CoV-2 infection of both the lung and brain in hACE2-transgenic mice. Site-directed mutagenesis analyses revealed that GW01 and REGN10989 bind to the receptor-binding domain in different epitopes and from different directions. Since G9 targets the epitopes for both GW01 and REGN10989, it was effective against variants with resistance to GW01 or REGN10989 alone and other NAb-escape variants. Therefore, this novel bispecific antibody, G9, is a strong candidate for the treatment and prevention of infection by SARS-CoV-2, NAb-escape variants, and other sarbecoviruses that may cause future emerging or re-emerging coronavirus diseases.

学科与关键词

关键词
CORONAVIRUS
相关
加载中…
  • Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
    Wang, Yingdan; Zhang, Xiang; Ma, Yunping; Wang, Yanqun; Zhan, Wuqiang; Zheng, Qinwen; Zhang, Meng; Ji, Ping; Liu, Mei; Liu, Qianying; Sun, Tingting; Zhu, Tongyu; Wen, Yumei; Sun, Lei*; Zhao, Jincun*; Wu, Fan*; Chen, Zhenguo*; Huang, Jinghe*Cell Discovery, 2022, 8(1): 104.被引 8
  • A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
    Yuan, Mengqi; Chen, Xiangyu; Zhu, Yanzhi; Dong, Xiaoqing; Liu, Yan; Qian, Zhaohui*; Ye, Lilin*; Liu, Pinghuang*Journal of Virology, 2022, 96(16).被引 6
  • Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain
    Wang, Yanqun*; Zhang, Zhaoyong; Yang, Minnan; Xiong, Xinyi; Yan, Qihong; Cao, Lei; Wei, Peilan; Zhang, Yuting; Zhang, Lu; Lv, Kexin; Chen, Jiantao; Liu, Xuesong; Zhao, Xiaochu; Xiao, Juxue; Zhang, Shengnan; Zhu, Airu; Gan, Mian; Zhang, Jingjun; Cai, Ruoxi; Zhuo, Jianfen; Zhang, Yanjun; Rao, Haiyue; Qu, Bin; Zhang, Yuanyuan; Chen, Lei; Dai, Jun; Cheng, Linling; Hu, Qingtao; Chen, Yaoqing; Lv, Huibin; So, Ray T. Y.; Peiris, Malik; Zhao, Jingxian; Liu, Xiaoqing*Cell Reports, 2024, 43(1): 113653.
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell Discovery
发表日期
2022-04-21
卷期
第 8 卷, 第 1 期
页码
36
DOI
10.1038/s41421-022-00401-6
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [31771008, 32022037]; National Major Science and Technology Projects of China [2017ZX10202102, 2018ZX10301403]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29010101]; Hundred Talent Program of Shanghai Municipal Health Commission [2018BR08]; Chinese Academy of Medical Sciences [2019PT350002]; SARS-CoV-2 Emergency Project of the Science and Technology Department of Zhejiang Province [2020C03129]; China Postdoctoral Science Foundation [2020M681937]; National Postdoctoral Program for Innovative Talents of China [BX20200304]; Leading Innovative and Entrepreneur Team Introduction Program of Hangzhou; Tencent Foundation; Westlake Education Foundation

作者

  • W

    Wang, Yingdan (第一作者)

    fudan univ · cams

  • L

    Liu, Meiqin

查看全部 26 位作者收起作者
  • S

    Shen, Yaping

    fudan univ · cams

  • M

    Ma, Yunping

    fudan univ · cams · shanghai jiao tong univ

  • L

    Li, Xiang

    cams · fudan univ

  • Z

    Zhang, Yuanyuan

  • L

    Liu, Mei

  • Y

    Yang, Xing-Lou

    chinese acad sci · wuhan inst virol, cas

  • C

    Chen, Jun

    cams · fudan univ

  • Y

    Yan, Renhong

  • L

    Luan, Die

    fudan univ · cams

  • W

    Wang, Yanqun

    1 · guangzhou med univ

  • C

    Chen, Ying

    univ chinese acad sci · chinese acad sci · wuhan inst virol, cas

  • W

    Wang, Qimin

    cams · fudan univ

  • L

    Lin, Haofeng

    univ chinese acad sci · chinese acad sci · wuhan inst virol, cas

  • L

    Li, Yaning

  • W

    Wu, Kaiyue

    fudan univ · cams

  • Z

    Zhu, Tongyu

    cams · fudan univ

  • Z

    Zhao, Jincun

    1 · guangzhou med univ

  • L

    Lu, Hongzhou

    cams · fudan univ

  • W

    Wen, Yumei

    cams · fudan univ

  • J

    Jiang, Shibo

    cams · fudan univ

  • W

    Wu, Fan

    shanghai jiao tong univ

  • Z

    Zhou, Qiang

  • S

    Shi, Zheng-Li

    chinese acad sci · wuhan inst virol, cas

  • H

    Huang, Jinghe

    fudan univ · cams

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417